SC 13G/A

SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON

Company: JOHNSON & JOHNSON
Filed: January 11, 2023
Accession Number: 0000904454-23-000019

View Document ↗ View on SEC.gov ↗